These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 12127302

  • 1. The relationship between serum levels of insulin-like growth factor-I and its binding proteins and microvascular function in acromegalic patients.
    Krsek M, Prázný M, Marek J, Skrha J, Justová V, Lacinová Z.
    Growth Horm IGF Res; 2002 Feb; 12(1):54-9. PubMed ID: 12127302
    [Abstract] [Full Text] [Related]

  • 2. [Changes in serum levels of IGF-I and its binding proteins and their relation to microcirculation in obese patients].
    Krsek M, Prázný M, Sucharda P, Marek J, Justová V, Lacinová Z.
    Vnitr Lek; 2001 Dec; 47(12):847-51. PubMed ID: 11826548
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of the acid-labile subunit in acromegaly: evaluation in comparison with insulin-like growth factor (IGF) I, and IGF-binding protein-1, -2, and -3.
    Arosio M, Garrone S, Bruzzi P, Faglia G, Minuto F, Barreca A.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1091-8. PubMed ID: 11238491
    [Abstract] [Full Text] [Related]

  • 4. The ratio between serum levels of insulin-like growth factor (IGF)-I and the IGF binding proteins (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients.
    Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE.
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):85-93. PubMed ID: 7519529
    [Abstract] [Full Text] [Related]

  • 5. High levels of 150-kDa insulin-like growth factor binding protein three ternary complex in patients with acromegaly and the effect of pegvisomant-induced serum IGF-I normalization.
    Parkinson C, Flyvbjerg A, Trainer PJ.
    Growth Horm IGF Res; 2004 Feb; 14(1):59-65. PubMed ID: 14700556
    [Abstract] [Full Text] [Related]

  • 6. [Microvascular reactivity in type 2 diabetes mellitus and its relation to IGF-I and its binding proteins].
    Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z, Haas T.
    Vnitr Lek; 2003 Jul; 49(7):535-40. PubMed ID: 12931435
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic value of serum IGF-I and IGFBP-3 in growth hormone disorders in adults.
    Kim HJ, Kwon SH, Kim SW, Park DJ, Shin CS, Park KS, Kim SY, Cho BY, Lee HK.
    Horm Res; 2001 Jul; 56(3-4):117-23. PubMed ID: 11847474
    [Abstract] [Full Text] [Related]

  • 8. Serum IGF-I and IGFBP-3 levels for the assessment of disease activity of acromegaly.
    Chen HS, Lin HD.
    J Endocrinol Invest; 1999 Feb; 22(2):98-103. PubMed ID: 10195375
    [Abstract] [Full Text] [Related]

  • 9. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
    Marzullo P, Di Somma C, Pratt KL, Khosravi J, Diamandis A, Lombardi G, Colao A, Rosenfeld RG.
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
    [Abstract] [Full Text] [Related]

  • 10. Paradoxical elevations in serum IGF-II and IGF binding protein-2 in acromegaly: insights into the regulation of these peptides.
    Renehan AG, Toogood AA, Ryder WD, Jones J, Potten CS, O'Dwyer ST, Shalet SM.
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):469-75. PubMed ID: 11678829
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factors and insulin-like growth factor binding proteins in adult patients with severe liver disease before and after orthotopic liver transplantation.
    Weber MM, Auernhammer CJ, Lee PD, Engelhardt D, Zachoval R.
    Horm Res; 2002 Oct; 57(3-4):105-12. PubMed ID: 12006706
    [Abstract] [Full Text] [Related]

  • 12. Monitoring of treatment success in patients with acromegaly: the value of serum insulin-like growth factor binding protein-3 and serum leptin measurements in comparison to plasma insulin-like growth factor I determination.
    Páramo C, Fluiters E, de la Fuente J, Andrade A, García-Mayor RV.
    Metabolism; 2001 Sep; 50(9):1117-21. PubMed ID: 11555849
    [Abstract] [Full Text] [Related]

  • 13. Effect of chronic treatment with octreotide nasal powder on serum levels of growth hormone, insulin-like growth factor I, insulin-like growth factor binding proteins 1 and 3 in acromegalic patients.
    Invitti C, Fatti L, Camboni MG, Porcu L, Danesi L, Delitala G, Cavagnini F.
    J Endocrinol Invest; 1996 Sep; 19(8):548-55. PubMed ID: 8905479
    [Abstract] [Full Text] [Related]

  • 14. [IGFBP-1 and its protective role in the pathogenesis of microangiopathy in type 1 diabetes mellitus].
    Krsek M, Prázný M, Skrha J, Justová V, Lacinová Z.
    Cas Lek Cesk; 2001 Apr 26; 140(8):234-7. PubMed ID: 11392040
    [Abstract] [Full Text] [Related]

  • 15. Increased levels of insulin-like growth factor binding protein-2 in sera and tumours from patients with colonic neoplasia with and without acromegaly.
    Miraki-Moud F, Jenkins PJ, Fairclough PD, Jordan S, Bustin SA, Jones AM, Lowe DG, Monson JP, Grossman AB, Besser GM, Camacho-Hübner C.
    Clin Endocrinol (Oxf); 2001 Apr 26; 54(4):499-508. PubMed ID: 11318786
    [Abstract] [Full Text] [Related]

  • 16. Comparative study of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) level and IGF-I/IGFBP-3 ratio measurements and their relationship with an index of clinical activity in the management of patients with acromegaly.
    Páramo C, Andrade O MA, Fluiters E, Luna R, de la Fuente J, García-Mayor RV.
    Metabolism; 1997 May 26; 46(5):494-8. PubMed ID: 9160813
    [Abstract] [Full Text] [Related]

  • 17. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
    Charalampaki P, Hildebrandt G, Schaeffer HJ, Schönau E, Klug N.
    Exp Clin Endocrinol Diabetes; 1998 May 26; 106(2):130-4. PubMed ID: 9628244
    [Abstract] [Full Text] [Related]

  • 18. Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency.
    Skjaerbaek C, Frystyk J, Kaal A, Laursen T, Møller J, Weeke J, Jørgensen JO, Sandahl Christiansen J, Orskov H.
    Clin Endocrinol (Oxf); 2000 Jan 26; 52(1):25-33. PubMed ID: 10651750
    [Abstract] [Full Text] [Related]

  • 19. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease.
    Krassas GE, Pontikides N, Kaltsas T, Dumas A, Frystyk J, Chen JW, Flyvbjerg A.
    J Clin Endocrinol Metab; 2003 Jan 26; 88(1):132-5. PubMed ID: 12519841
    [Abstract] [Full Text] [Related]

  • 20. The role of IGF binding protein-3 as a parameter of activity in acromegalic patients.
    Halperin I, Casamitjana R, Flores L, Fernandez-Balsells M, Vilardell E.
    Eur J Endocrinol; 1999 Aug 26; 141(2):145-8. PubMed ID: 10427158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.